e-learning
resources
Vienna 2003
Wednesday 01.10.2003
The various appearance of resistance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
DOTS program is associated with a reduction of multidrog resistant tuberculosis prevalence in new cases
S. A. Antoniu, T. T. Mihaescu (Iasi, Romania)
Source:
Annual Congress 2003 - The various appearance of resistance
Session:
The various appearance of resistance
Session type:
Oral Presentation
Number:
3491
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. A. Antoniu, T. T. Mihaescu (Iasi, Romania). DOTS program is associated with a reduction of multidrog resistant tuberculosis prevalence in new cases. Eur Respir J 2003; 22: Suppl. 45, 3491
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia
Source: ERJ Open Res, 6 (1) 00030-2019; 10.1183/23120541.00030-2019
Year: 2020
Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey
Source: Eur Respir J, 51 (3) 1702571; 10.1183/13993003.02571-2017
Year: 2018
TB drug resistance in high-incidence countries
Source: Eur Respir Mon 2012; 58: 95-110
Year: 2012
Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
A study of prevalence of depression in patients with multi drug resistant tuberculosis
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
The prevalence of drug resistance tuberculosis in previously treated patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept